MétaCan
Menu
Back to cohort

Abstract P84: Antithrombotic Treatment Patterns, Hospitalizations, and Associated Costs in Acute Coronary Syndrome (ACS) Patients

2011· article· en· W2595719993 on OpenAlexaff
Patrick Lefèbvre, François Laliberté, Katherine Dea, Winnie W. Nelson, Concetta Crivera, Lorie Ellis, Jeff Schein, C.V. Damaraju, Samir H. Mody, Mei Sheng Duh

Bibliographic record

VenueCirculation Cardiovascular Quality and Outcomes · 2011
Typearticle
Languageen
FieldMedicine
TopicMedication Adherence and Compliance
Canadian institutionsGroup for Research in Decision Analysis
Fundersnot available
KeywordsMedicineAntithromboticAcute coronary syndromeIncidence (geometry)Medical prescriptionAntiplatelet drugInternal medicineEmergency medicineAspirinPediatricsClopidogrelMyocardial infarction

Abstract

fetched live from OpenAlex

Background: We investigated real-world patterns of use of antithrombotic therapy among ACS patients to evaluate the level of undertreatment, nonadherence to medication use, recurrence of cardiovascular events, and associated costs. Methods: We analyzed the PharMetrics Integrated Claims database from 01/2004 through 12/2009. Patients ≥18 years old with ≥1 claim for ACS during a hospitalization or emergency department visit were included. Adherence to antiplatelet therapy was estimated using proportion of days covered (PDC) by drug available. Persistence was defined as continuous drug claims without a gap of ≥30 days between refills. Major outcomes were cardiovascular disease (CVD)-related hospitalization, readmission, and length of stay. We reported all-cause and CVD-related per-patient-per-month (PPPM) healthcare costs. Incidence rates of major outcomes were calculated as number of patients with an event divided by patient-years of observation, censored at the time of the first event. Results: Among the 173,573 ACS patients, mean age was 55.4 years; 36% (62,914 of 173,573) were female. During follow-up, 36.2% (62,774 of 173,573) and 5.0% (8685 of 173,573) had antiplatelet or anticoagulant prescriptions; 3.4% (5866 of 173,573) had both. Mean duration of antiplatelet therapy was 457 days. At 1.5, 6, and 12 months, mean PDCs were 0.93, 0.78, and 0.70. Kaplan-Meier rates of persistence after 6 and 12 months were 0.66 and 0.47. The incidence rate of CVD-related hospitalization was 0.22 events per patient-year of observation. The rates of CVD-related and all-cause hospital readmissions were 0.32 and 0.41 events per patient-year; mean length of stay was 7.1 and 6.8 days per rehospitalization. All-cause healthcare cost PPPM was $2419; 63% ($1518 of $2419) of total all-cause costs PPPM were associated with claims for CVD-related hospitalization. Conclusions: This observational study suggests undertreatment in secondary prevention of ACS. Persistence with antiplatelet therapy dropped dramatically by 6 months after the initial event. ACS patients have a high risk of repeated CVD-related hospitalizations that incur high costs to the healthcare system. Interventions to improve long-term use of evidence-based therapies may improve ACS management.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.012

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0020.003
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.067
GPT teacher head0.311
Teacher spread0.243 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueCirculation Cardiovascular Quality and OutcomesSame topicMedication Adherence and ComplianceFrench-language works237,207